In contrast, mutants of cFos—which enhances stability, DNA binding activity [41], and transactivation activity [40] of AP-1 heterodimers—may be more powerful drivers of dysregulated AP-1 activity in RA. This evidence concerns the gene JUN and rheumatoid arthritis.